A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration

A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration

(2011)

Paperback
108 pages | 6 x 9
978-0-309-21280-9

Get the book now

STATUS » FINAL
Paperback
108 pages | 6 x 9
978-0-309-21280-9

  • Overview
  • Table of Contents
  • Related Resources

Authors

Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council

Suggested Citation

National Research Council. A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration. Washington, DC: The National Academies Press, 2011.

Import this citation to:



ALSO OF INTEREST